Print Friendly, PDF & Email

NCT/Study#

NA /

KB-ENTO-3001

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia

DISEASE GROUP:
Leukemia
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: